The stock price of Kopran has been on a consistent decline, falling for six consecutive trading sessions and registering a cumulative return of -14.36% during this period. Today's closing price of Rs.137 represents the lowest level the stock has traded at in the past year, a notable drop from its 52-week high of Rs.236.1. This decline comes despite the broader market's mixed performance, with the Sensex opening positively but eventually retreating by 381.14 points, or -0.34%, to trade at 84,661.23. The Sensex remains close to its 52-week high, just 0.74% away, and is trading above its 50-day and 200-day moving averages, indicating a generally bullish market environment contrasting with Kopran's performance.
Kopran's stock is currently trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This technical positioning underscores the stock's weak momentum relative to its historical price levels. The stock's underperformance is also evident when compared to the sector, as it lagged by 0.74% today.
Is Kopran your best bet? SwitchER suggests better alternatives across peers, market caps, and sectors. Discover stocks that could deliver more for your portfolio!
- Better alternatives suggested
- Cross-sector comparison
- Portfolio optimization tool
Over the past year, Kopran has generated a return of -38.07%, a stark contrast to the Sensex's positive return of 9.48% over the same period. The stock has also underperformed the BSE500 index across multiple time frames, including the last three years, one year, and three months. This sustained underperformance highlights the challenges faced by the company in maintaining shareholder value.
Financially, Kopran has reported a decline in net sales by 22.2% in its most recent quarterly results, which were declared in September 2025. This marks the fifth consecutive quarter of negative results for the company, following a similar pattern observed since September 2024. The net profit after tax (PAT) for the quarter stood at a loss of Rs.9.92 crore, reflecting a fall of 234.4% compared to the previous period. Such figures indicate a contraction in profitability and operational efficiency.
Return on Capital Employed (ROCE) for the half-year period is reported at 5.38%, one of the lowest levels recorded for the company. Additionally, the operating profit to interest coverage ratio for the quarter is at -2.53 times, signalling challenges in covering interest expenses from operating profits. These metrics point to subdued financial health and pressure on earnings quality.
Kopran's long-term growth trajectory also shows subdued trends, with operating profit exhibiting an annual rate of decline of 11.79% over the last five years. This trend aligns with the recent negative quarterly results and the stock's price performance, suggesting persistent headwinds in the business environment or competitive landscape.
Despite these challenges, Kopran maintains a relatively low average debt-to-equity ratio of 0.23 times, indicating limited leverage on its balance sheet. The company’s valuation metrics show an enterprise value to capital employed ratio of 1.3, which is comparatively attractive relative to its peers’ historical averages. However, the stock’s discounted valuation has not translated into positive returns or improved financial outcomes over the past year, as profits have declined by 66.7% during this period.
Holding Kopran from Pharmaceuticals & Biotechnology? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!
- Peer comparison ready
- Superior options identified
- Cross market-cap analysis
Market participation by domestic mutual funds in Kopran remains minimal, with holdings at just 0.01%. Given the capacity of these funds to conduct detailed research, this small stake may reflect a cautious stance towards the stock’s current valuation or business outlook. The limited institutional interest adds another dimension to the stock’s subdued market performance.
In summary, Kopran’s stock has reached a significant 52-week low of Rs.137 amid a backdrop of declining sales, consecutive negative quarterly results, and subdued profitability metrics. While the broader market and sector indices show relative strength, Kopran’s price and financial indicators highlight ongoing challenges. The stock’s position below all major moving averages and its underperformance relative to benchmarks underscore the current market sentiment towards the company.
Limited Time Only! Subscribe for Rs. 12,999 and get 1 Year of MojoOne + an Additional Year Completely FREE. Don't miss out on this exclusive offer. Claim Your Free Year →
